Indiana Congressmen Rudy Yakym and André Carson have introduced a bipartisan bill aimed at cracking down on untested and potentially dangerous mass-produced compounded drugs. The proposal, called the SAFE Drugs Act of 2025 (H.R. 6509), would require regular inspections of compounding facilities, strengthen reporting requirements, and give the FDA more resources to monitor drug safety. Yakym said the bill is meant to restore confidence in prescription medications by ensuring they are safe, effective, and made to high standards. Carson added that some companies are selling risky, substandard products, and the legislation would tighten oversight and improve quality controls. Several major patient-advocacy groups have endorsed the measure, citing growing concerns about widely marketed, n

See Full Page